Table 3.
Number of ICSRs without other suspected/interacting/concomitant drugs.
Statins | Number of ICSRs That Do Not Mention Another Suspected Drug/Interacting Drug (%) | Number of ICSRs That Do Not Mention Another Concomitant Drug (%) |
---|---|---|
Atorvastatin | 1983 (54.20) | 1765 (48.24) |
Simvastatin | 557 (23.95) | 809 (34.78) |
Rosuvastatin | 845 (43.07) | 764 (38.94) |